News and Views

Starting from basic biology, the Yang lab sheds light on an incurable disease.

The compound from the Griffin lab could avoid the troubling side effects of current anti-diabetic drugs.

The study from the Wiseman and Kelly labs shows a way to boost a cell’s ability to catch "typos" in protein production that cause amyloidosis.

The Loring lab will lead the two-year project that will test the safety and quality of a potential cell therapy.

TSRI Awarded $20M for First Year of US Precision Medicine Initiative Cohort Program
Tendon, Heal Thyself!
Team Reveals Single-Neuron Gene Landscape of the Human Brain
Scientists Find New Cancer Drug Target in Dual-Function Protein
New TSRI Method Opens Door to Development of Many New Medicines
Discovered: A New Protein Crucial to Normal Forgetting
Skaggs Family Gives $2 Million for New TSRI Graduate Program Endowment
Harnessing Nature's Vast Array of Venoms for Drug Discovery
TSRI Celebrates 24th Commencement
Researchers Pioneer a Breakthrough Approach to Breast Cancer Treatment
Scientists Design Potent Therapeutic ‘Warheads’ That Target Cancer Cells
Team Streamlines Biomedical Research by Making Genetic Data Easier to Search
'An Excellent Time for Neuroscience': An Interview with Hollis Cline
Scientists Find Root Cause of Appetite Loss During Illness
New Method Enlists Electricity for Easier, Cheaper, Greener Chemistry
Scientists Reveal Secrets of a Deadly Virus Family